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Igs can be expressed in two different ways depending on the developmental
stage of B lymphocytes. Immunocompetent B cells carry Igs as receptors on the
cell surface, while terminally differentiated plasma cells secrete the molecules in
large amounts. The structural differences between membrane-bound and se-
creted antibodies are located in the COOH-terminal portion of the H chains (1).
Both types of H chains are encoded by the same gene. As it has been shown
for the A chain, two mRNAs differing in their 3' end can be transcribed from
the A gene by alternative usage of two potential polyadenylation sites (2). Those
transcripts (membrane-bound u chain [Am] and secreted A. chain [As] mRNA) are
generated in B lymphocytes in a developmentally ordered fashion. In Abelson
virus-transformed pre-B cells, equal amounts of Am and As mRNA are tran-
scribed (3); in B cell lymphomas the ratio is shifted to the Am form (2); while in
plasmacytomas, As mRNA is found nearly exclusively (2).
We have introduced a Am expression vector into B cell lines representing
different developmental stages. In the presence of L chain, only in B lymphoma
but not in myeloma cells, the membrane-bound IgM molecule was expressed on
the cell surface, although fully assembled intracellular IgM antibodies could be
identified in both cell lines.
Materials and Methods
BriefDefinitive Report
The following vectors were used in cell transfection experiments: pSVAm38 encodes
for a complete H chain, whose CI gene is cDNA derived, so that exclusively Am mRNA
is transcribed (see also reference 4). The VHDJH gene is genomic and cloned from the
hybridoma Ac38 (5). The plasmid pSVumk38 carries the Ac38 7C chain gene in addition,
and both H and L chains are under control of their natural promotor and enhancer
sequences. The original vector is pSV2gpt (6) (both vectors will be described in detail
elsewhere). The cells used for transfection were the myeloma cellsJ558L (7), a X chain
producer, X63-Ag8 .653 (8), an Ig nonproducer, and A20 (9), a B lymphoma line that
carries antibodies of the IgG2a/x isotype on the surface. All cells were grown in DMEM
culture medium supplemented with 10% FCS, 2 MM t.-glutamine, 50 U/ml penicillin, 50
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mg/ml streptomycin,and 2 x 10-5 M 2-ME. Thecells were transfected by electroporation
(10), distributed into 48-well plates, and selected by mycophenolic acid. Fluorochrome
conjugates were purchased from Southern Biotechnology Associates, Inc., Birmingham,
AL. Cytoplasmic (8) and surface stainings (11) were analyzed by fluorescence microscopy;
surface stainings were analyzed, in addition, in the FACS (model 440; Becton Dickinson
& Co., Mountain View, CA). K chains were detected with FITC-coupled goat anti-,u
antiserum. The Ac38 V-region was identified by the antiidiotypic IgM/X, antibody B1-8
(12), whose binding was detected by goat anti-X coupled to FITC. For biosynthetic
labeling, 5 x 10' cells were incubated with 125 uCi [S5S]methionine (1,000 Ci/mM;
Amersham Corp., Braunschweig, FRG) for 3 h in culture medium after a preincubation
over a period of 1.5 h in medium without methionine. Cell labeling, cell lysis, and
precipitation of the Igs by Sepharose-bound antibodies were done according to reference
13. Endoglycosidase H (Endo H) treatment was done after precipitation in 50 mM citrate
buffer, pH 5.5, 0.02% SDS, 0.1 M 2-ME, and 0.5 mM PMSF with 6 mU Endo H
(Boehringer Mannheim, FRG) over 5 h. The proteins were separated by SDS-PAGE as
described in reference 14 and two-dimensional gel analysis was performed according to
reference 15.
Results and Discussion
To analyze the expression of membrane-bound Igs in myeloma cells, the
plasmid pSV1zmk38, encoding a um chain and a X chain, was stably introduced
into the Ig-negative myeloma line X63-Ag8.653. Additionally, the um chain
encoding construct pSVum38 was transfected into the X chain producing mye-
loma J558L. The transfected cells, X63umk38 and J558Lum38, were subse-
quently analyzed for surface IgM expression. As a control we also analyzed the
um transfectant A20um38 of the B lymphoma line A20 that carries surface
IgG2a/x.
While A20um38 cells express high amounts of the transfected um chain on
their surface (Fig. 1A), no IgM was detected on the surface of the X63umk38
(Fig. 1 C) and J558LAm38 transfectant (not shown). Indeed, X63umk38 cells
were as negative as the untransfected control lines A20 and X63-Ag8.653 (Fig.
1, B and D).
On the other hand, intracellular Rm chain was identified in all transfected cell
lines by cytoplasmic staining (data not shown). Furthermore, BI-8 (12), the
antigen of Ac38 (5), was clearly bound as shown by intracellular staining of
X63umk38, suggesting that functional antibodies are assembled inside the mye-
loma but obviously do not appear on the surface. AnotherJ558L transfectant,
containing a um vector encoding the B1-8 VH gene (4), gave identical staining
results; i.e., no surface but intracellular u chain was detected (data not shown).
This indicates that lack of surface expression of the membrane-bound antibody
is independent of its V region.
The correctassembly of the antibody was also shown in a biochemical analysis
of the intracellular antibodies in X63umk38 and A20um38 (Fig. 2). The Igs
were biosynthetically labeled, precipitated from cell lysate by Sepharose-coupled
anti-X antibody, and subsequently analyzed on an acrylamide gel under reducing
and nonreducing conditions. From both transfectants, H chains were coprecipi-
tated with the L chains in roughly equal amounts (Fig. 2, lanes 2 and 3). In lane
1 the precipitate from the myeloma line was size fractionated undernonreducing
conditions; apart from the free L chain, the HL dimer and also the complete
antibody can be detected. These data prove that at least a significant fraction of654
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FIGURE 1 .
￿
FACS histograms of surface-stained myeloma and B lymphoma cells. Cells were
stained with FITC-coupled goat anti-g antiserum . 10' cells were analyzed per histogram . (A)
Transfected B cell lymphoma A20,um38 ; (B) untransfected lymphoma cells ; (C) transfected
myeloma cell X631mk38 ; (D) untransfected myeloma cells .
FIGURE 2 .
￿
SDS-PAGE of biosynthetically labeled and immu-
noprecipitated antibodies . X63,umk38and A20Wm38 cells were
biosynthetically labeled with [' SS]methionine andthe Igs precip-
itated from the cell lysate by monoclonal anti X antibody R33-
18 (16),bound to Sepharose . Equivalent amounts were analyzed .
Immunoprecipitated material from X63,umk38, under (lane 1)
noureducing and (lane 2) reducing conditions . (Lane 3) Precip-
itated proteins from A20,m38 under reducing conditions ; the
proteins were size fractionated by SDS-PAGE on a gel with a
linear acrylamide gradient from 5 to 15% .
the Am chains in the transfected myeloma cells is associated with L chain to full
size antibodies .
Evidence for biochemical identity of theAm chains derivedfrom the lymphoma
and myeloma cells was obtained by two-dimensional gel analysis ; the Am chains
from the X63Amk38 (Fig . 3A) and the A20/.tm38 transfectant (Fig . 3B) were
indistinguishable after IEF and subsequent size separation by SDS-PAGE . ThisHOMBACH ET AL .
￿
BRIEF DEFINITIVE REPORT
￿
655
FIGURE 3 .
￿
Two-dimensional gels of biosynthetically labeled J .
chains. The cell lines (A) A20pm38 and (B) X63pmk38 were
biosynthetically labeled with ["S]methionine andthe Igs precip-
itated from cell lysate by goat anti-ji-coupled Sepharose . First
dimension : IEF gel ; second dimension : 10% SDS-PAGE . For
orientation, marker proteins were loaded together with the
precipitates onto gel . Arrows indicate the W chains.
FIGURE 4.
￿
Endo Hdigest ofy chains from different
cell lines . [' SS]Methionine biosynthetically labeled ju
chains were precipitated from cell lysate by goat anti-
,u-coupled Sepharose. The proteins were size sepa-
ratedon a 10% acrylamide gel after being reduced in
the presence of 2-ME . (+) Indicates Endo H treat-
ment. Lanes 1 and 2 show um chains from
J558LIAm38 ; lanes3and4 from X631Amk38 ; and lanes
5and 6 from A20jum38 .
result was expected, since in both transfectantsAm transcripts of the correct size
(2.7 kb) could be detected with a probe specific for the sequence encoding the
membrane portion of the Am chain (data not shown) . We conclude that the Am
proteins in the myeloma and B lymphoma are identical, despite their different
behavior in the cells.
Where in the myeloma cells is IgM arrested? Treatment of glycoproteins with
Endo H gives information about their intracellular location . Only the rough
endoplasmic reticulum-specific high-mannose glycosylation type is sensitive to
the enzyme . Glycoproteins that reach the Golgi apparatus become complexly
glycosylated and their sugar chains are no longer cleaved by Endo H.
The analysis of the Am chains from X63Amk38, J558LAm38, and A20Am38
is depicted in Fig. 4 . The undigested H chains of the myeloma cells (Fig . 4, lanes
1 and 3) show the molecular mass of the high-mannose glycosylated form (73
kD). Upon Endo H treatment all these chains are deglycosylated to a molecular
mass of 62 kD (Fig . 4, lanes 2 and 4) . In contrast, in the B lymphoma, the Am
protein is partly resistant to the enzyme . The undigestible material has a molec-
ular mass of 78 kD, the size expected forAm chains carrying the complex sugar
trees (Fig. 4, lane 6 [reference 17]) . Thus, in the B lymphoma the membrane-
boundantibodies reach the Golgi stack, in contrast towhat is seen in the myeloma
cells . A similar situation to theB lymphoma was observed in a Am/X transfected
Abelson pre-B cell line (see reference 4) . The presence of only small amounts of656
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complexly glycosylated um proteins in the B lymphoma may be due to different
Am chain pool sizes in endoplasmic reticulum and Golgi complex .
Our data show that myeloma cells are unable to bring membrane-bound
antibodies to the cell surface . However, these same cells can express on their
surface the product of a transfected class I MHC gene (Weichel, W ., personal
communication), and thusdo notseem to be generally deficient in transport and
surface expression of membrane-bound proteins . The block of transport seems
to be specific for the membrane-bound antibody molecule .
In principle, the selectivity ofIgM transport can be due to two different kinds
of control, depending on whether the proteins are targeted to the cell surface
via a positively or negatively regulated mechanism . In the B lymphoma, surface
expression of the antibody may occur only in concert with a second protein,
whose expression is turned off in myeloma cells . This protein may play a role in
the export ofthe antibody moleculeand/or constitute with the antibody molecule
part of an active antigen receptor complex on the surface of the B cell . Such a
situation would be analogous to the antigen receptor on the T cell, where the
T3 proteins are involved in function and transport of the a# heterodimer (18) .
This is in line with the- finding that T cell receptor and surface Ig trigger a
similar cellular response upon ligand crosslinking (19, 20) .
The alternative, namely that transport of membrane-bound Ig is negatively
regulated in myeloma cells, implies a specific factor that hinders membrane-
bound antibodies from being transported to the cell surface . Recent studies on
protein transport, especially on secreted molecules, give increasing evidence that
protein sorting occurs by selective retention (21) . Active retention of membrane-
bound antibodies in myeloma cells would prohibit antigen triggering at this
developmental stage .
Summary
Expression vectors coding for membrane-bound IgM antibodies were intro-
duced into myeloma and B lymphoma cells . Only the lymphoma but not the
myeloma cells were able to express the antibodies on the cell surface, although
in both cases, complete antibodies were assembled intracellularly . In myeloma
cells, the Ig molecules did not reach the Golgi compartment . Thus, the intracel-
lular transport of membrane-bound antibodies is controlled in the B cell lineages
in a developmentally ordered fashion .
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